KBLB.US Kraig Biocraft Labs
- Market cap
- USD 89.2M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is KBLB.US undervalued?
Graham numberThe Graham number of Kraig Biocraft Labs cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Kraig Biocraft Labs fundamental analysis
No fundamental analysis for Kraig Biocraft Labs yet.
Kraig Biocraft Labs stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Kraig Biocraft Labs
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products…
Full company profileKraig Biocraft Labs financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Kraig Biocraft Labs annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 31.9K | 97.3K | 402K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 31.9K | 97.3K | 402K | - | - | - | - | - | - | - | - |
| Operating Income | -2.95M | -2.16M | -960K | -2.62M | -4.53M | -2.76M | -2.12M | -2.61M | -3.07M | -3.37M | -3.06M |
| EBITDA | - | -2.14M | -913K | -2.58M | -4.56M | -2.64M | -3.20M | -2.52M | -2.84M | -3.03M | -3.08M |
| Net Income | -3.07M | -2.33M | -1.17M | -2.91M | -4.97M | -8.05M | -3.84M | -3.03M | -3.40M | -3.62M | -3.70M |
| EPS | - | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 384K | 114K | 71.4K | 751K | 1.28M | 3.02M | 4.57M | 3.23M | 1.51M | 2.57M | 4.27M |
| Total Liabilities | 2.74M | 3.49M | 4.53M | 6.14M | 7.85M | 8.32M | 8.09M | 8.94M | 9.65M | 10.6M | 11.0M |
| Shareholders' Equity | -2.36M | -3.38M | -4.46M | -5.39M | -6.57M | -5.30M | -3.52M | -5.71M | -8.15M | -8.00M | -6.75M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 125K | 817K | 2.36M | 3.86M | 2.55M | 673K | 1.79M | 3.39M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.01M | -730K | -235K | -1.09M | -1.25M | -1.80M | -1.89M | -1.24M | -1.84M | -1.79M | -2.26M |
| Capital Expenditure | 2.49K | 31.2K | 11.4K | 101K | 97.2K | 97.2K | 5.02K | 6.40K | 4.24K | 5.40K | 85.4K |
| Free Cash Flow | - | -761K | -246K | -1.19M | -1.25M | -1.90M | -1.89M | -1.25M | -1.84M | -1.79M | -2.34M |
| Ratios | |||||||||||
| ROA | -801.2% | -2,037.7% | -1,637.6% | -387.5% | -389.2% | -266.2% | -84.1% | -93.7% | -225.8% | -141.2% | -86.7% |
| Net Profit Margin | -9,648.6% | -2,397.4% | -291.1% | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Kraig Biocraft Labs dividends
Kraig Biocraft Labs has not paid dividends in the last 9 fiscal years.
Last stock split: 10:1 on May 28, 2009.
Who owns Kraig Biocraft Labs
- Insiders 18.59%
- Institutions 0.00%
- Public & others 81.41%
- Shares outstanding 1.12B
- Free float 849M
Kraig Biocraft Labs company profile
- Company name
- Kraig Biocraft Labs
- Ticker
- KBLB.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 37
- Fiscal year end
- December
- Address
- 2723 South State Street, Ann Arbor, MI, United States, 48104
- Phone
- 734 619 8066
- Website
- kraiglabs.com
About Kraig Biocraft Labs
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Kraig Biocraft Labs management
4- Mr. Kim Kraig ThompsonFounder, CEO, President, CFO, Corporate Secretary & Director · born 1961
- Mr. Jonathan R. RiceChief Operating Officer · born 1980
- Mr. Kenneth LePresident of Prodigy Silk · born 1964
- Dr. Xiaoli ZhangChief Scientist